• 金年会诚信至上

    TMA-TNP Design

    Heidi S Feiler, Koei Chin

    Published: 2021-08-12 DOI: 10.17504/protocols.io.bn2fmgbn
    AI 解读
    浏览 1584

    Abstract

    Human Tumor Atlas Tissue MicroArrary TNP (TMA-TNP)

    The Tissue MicroArray (TMA) TNP will extend the SARDANA-TNP characterization and analytics methodologies for evaluation and validation on a large array of breast tumor samples that provide a broad spectrum of disease state and subtype. A commercially available anonymized breast tumor TMA was purchased and sections distributed to participating HTAN Centers. Some deidentified basic clinical data will also be provided. The participating HTAN Centers will characterize the FFPE specimens (e.g. by imaging) and generate a spatially resolved cell type/state census using each Center’s method of choice. Data will then be recorded in a common repository to enable joint analysis.

    This TNP has two specific Aims focused on (i) Data Collection and (ii) Data Coordination and Analysis. Individual Centers can participate in one or both aims.

    This protocol outlines the design of the TMAs and provides the basic clinical sample descriptions.

    Steps

    TMA Map of Participant IDs

    1.

    A custom breast TMA design generated by Dr. Koei Chin (OHSU) was sent to Pantomics for TMA FFPE block generation and sectioning. The randomized array design, outlined below, was used to generate 2 identical TMAs, TMA1 and TMA2. Cores from tumor samples with Pantomics Ref. No. were arrayed as shown (the matching HTAN Participant IDs are also shown).

    ABC
    Array PositionPantomics Ref. No.HTAN Participant ID
    A01F11-0369HTA14_1
    A02F08-3884HTA14_2
    A03F11-0957HTA14_3
    A04F08-0824HTA14_4
    A05F18-0992HTA14_5
    A06255287-OHSUHTA14_6
    A07F13-1953HTA14_7
    A08F11-3564HTA14_8
    A09316473-OHSUHTA14_9
    A10F10-1047HTA14_10
    A11MCF10A-KCHTA14_11
    B01F16-0582HTA14_12
    B02HCC1143HTA14_13
    B03F08-1273HTA14_14
    B04F17-3395A3HTA14_15
    B05F10-0051HTA14_16
    B06F10-0992HTA14_17
    B07F09-1280HTA14_18
    B08HCC3153HTA14_19
    B09F16-0582HTA14_12
    B10F09-0328HTA14_20
    B11MDAMB436-KCHTA14_21
    C01F09-3051HTA14_22
    C02F13-0368HTA14_23
    C03F10-0572HTA14_24
    C04F09-1290HTA14_25
    C05F11-3564HTA14_8
    C06316473-OHSUHTA14_9
    C07F09-4287HTA14_26
    C08F10-0572HTA14_24
    C09F10-4365HTA14_27
    C10F08-1426HTA14_28
    C11HCC1143-KCHTA14_29
    D01255287-OHSUHTA14_6
    D02F16-2497HTA14_30
    D03F09-2873HTA14_31
    D04F10-0587HTA14_32
    D05T47DHTA14_33
    D06F09-0328HTA14_20
    D07F09-1814HTA14_34
    D08232527-OHSUHTA14_35
    D09AU565HTA14_36
    D10F08-3884HTA14_2
    D11HCC3153-KCHTA14_37
    E01F15-0002HTA14_38
    E02F08-0824HTA14_4
    E03326007-OHSUHTA14_39
    E04F18-0992HTA14_5
    E05F10-1015HTA14_40
    E06F11-0957HTA14_3
    E07F08-1273HTA14_14
    E08F09-3051HTA14_22
    E09F10-0587HTA14_32
    E10F08-0773HTA14_41
    E11AU565-KCHTA14_42
    F01F10-4365HTA14_27
    F02F09-4287HTA14_26
    F03F13-1953HTA14_7
    F04F09-3432HTA14_43
    F05F10-0342HTA14_44
    F06F15-0002A1HTA14_38
    F07F16-2497HTA14_30
    F08F10-1047HTA14_10
    F09F11-1210HTA14_45
    F10F09-2873HTA14_31
    F11BT474-KCHTA14_46
    G01F10-1015HTA14_40
    G02F09-1814HTA14_34
    G03F11-1210HTA14_45
    G04232527-OHSUHTA14_35
    G05F11-0369HTA14_1
    G06F08-0773HTA14_41
    G07F13-0368HTA14_23
    G08326007-OHSUHTA14_39
    G09F10-0992HTA14_17
    G10F09-1290HTA14_25
    G11T47D-KCHTA14_47
    H01BT474HTA14_48
    H02F09-3034HTA14_49
    H03F09-1280HTA14_18
    H04F08-1426HTA14_28
    H05MDAMB436HTA14_50
    H06F10-0051HTA14_16
    H07F09-3432HTA14_43
    H08F09-3034HTA14_49
    H09F17-3395HTA14_15
    H10F10-0342HTA14_44
    H11MCF10AHTA14_51

    TMA Clinical Sample Descriptions

    2.
    ABCDEFGH
    HTAN Participant IDAgeSexAnat. SitePathologyGradeClinic stage (TNM)Subtybe
    HTA14_2543FBreast Invasive ductal carcinoma IT2N2M0Luminal A
    HTA14_3455FBreast Invasive ductal carcinoma IIT2N2M0Luminal A
    HTA14_543FBreast Invasive ductal carcinoma IIT2N0M0Luminal A
    HTA14_1048FBreast Invasive ductal carcinoma IT1N1M0Luminal A
    HTA14_156FBreast Invasive ductal carcinoma IIT2N2M0Luminal A
    HTA14_1444FBreast Invasive ductal carcinoma IIT2N1M0Luminal B Her2+
    HTA14_2837FBreast Invasive ductal carcinoma IIT4N0M0Luminal B Her2+
    HTA14_2647FBreast Invasive ductal carcinoma IIT2N1M0Luminal B Her2+
    HTA14_4469FBreast Invasive ductal carcinoma IIT2N0M0Luminal B Her2+
    HTA14_3249FBreast Invasive ductal carcinoma IIT2N0M0Luminal B Her2+
    HTA14_4137FBreastInvasive ductal carcinoma IIIT1N0M0Luminal B HER-
    HTA14_443FBreastInvasive ductal carcinoma IIT1N0M0Luminal B HER-
    HTA14_2459FBreastInvasive lobular carcinoma IIT2N0M0Luminal B HER-
    HTA14_1743FBreastInvasive ductal carcinoma IIT2N0M0Luminal B HER-
    HTA14_4069FBreastInvasive ductal carcinoma IIT2N1M0Luminal B HER-
    HTA14_2065FBreast Invasive ductal carcinoma IIT2N0M0Her2 over-expression
    HTA14_1842FBreast Invasive ductal carcinoma IIIT2N0M0Her2 over-expression
    HTA14_3152FBreast Invasive ductal carcinoma IT2N2M0Her2 over-expression
    HTA14_2250FBreast Invasive ductal carcinoma IIT2N0M0Her2 over-expression
    HTA14_4340FBreast Invasive ductal carcinoma IIIT2N0M0Her2 over-expression
    HTA14_2732FBreast Invasive ductal carcinoma IIIT3N0M0TNBC
    HTA14_376FBreast Invasive ductal carcinoma IIT2N0M0TNBC
    HTA14_4551FBreast Invasive ductal carcinoma IIIT2N0M0TNBC
    HTA14_839FBreast Invasive ductal carcinoma IIT2N0M0TNBC
    HTA14_2330FBreast Invasive ductal carcinoma IIIT3N2M0TNBC
    HTA14_4967FBreast Invasive lobular carcinoma IIT3N1M0Invasive lobular carcinoma 
    HTA14_1655FBreast Invasive lobular carcinoma IIT4N3M0Invasive lobular carcinoma 
    HTA14_742FBreast Invasive lobular carcinoma IIT2N3M0Invasive lobular carcinoma 
    HTA14_1238FBreast Invasive lobular carcinoma IIT2N0M0Invasive lobular carcinoma 
    HTA14_3049FBreast Invasive lobular carcinoma IT3N2M0Invasive lobular carcinoma 
    HTA14_385MTonsilNormal TonsilNormal Tonsil
    HTA14_1568MJejunumNormal JejunumNormal Jejunum
    HTA14_13Breast cell lineHCC1143Basal Like
    HTA14_19Breast cell lineHCC3153Basal Like
    HTA14_33Breast cell lineT47DLuminal A
    HTA14_48Breast cell lineBT474Luminal B
    HTA14_36Breast cell lineAU565Her2 over-expression
    HTA14_50Breast cell lineMDAMB436Claudin Low
    HTA14_51Breast cell lineMCF10ACystic fibrosis
    HTA14_243FNormal BreastNormal Breast to IDCNB-1A
    HTA14_35Normal BreastNormal Adacent TissueNB-2A
    HTA14_6Normal BreastNormal Adacent TissueNB-3A
    HTA14_39Normal BreastTrue Normal NB-4A
    HTA14_9Normal BreastTrue Normal NB-5B
    HTA14_47Breast cell lineHCC1143Luminal A
    HTA14_46Breast cell lineHCC3153Luminal B
    HTA14_42Breast cell lineT47DHER2
    HTA14_37Breast cell lineBT474Basal Like
    HTA14_29Breast cell lineAU565Basal Like
    HTA14_21Breast cell lineMDAMB436Claudin Low
    HTA14_11Breast cell lineMCF10ACystic fibrosis

    推荐阅读

    Nature Protocols
    Protocols IO
    Current Protocols
    扫码咨询